Takashi Abe
- Promising effect of PMX-DHP absorption therapy for acute exacerbation of IPFBy Arata Azuma, Shinji Abe, Takashi Ogura, Hiroshi Mukae, Hiroyuki Taniguchi, Masashi Bando and Yukihiko SugiyamaArata Azuma1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanShinji Abe1Division of Respiratory Medicine, Infection and Oncology, Nippon Medical School, Tokyo, JapanTakashi Ogura2Respiratory Medicine, Kanagawa Cardiovascuiar and Respiratory Center, Yokohama, Kanagawa, JapanHiroshi Mukae3Department of Respiratory Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, JapanHiroyuki Taniguchi4Division of Respiratory Medicine, Allergic Internal Medicine, Tosei General Hospital, Seto, Aichi, JapanMasashi Bando5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, JapanYukihiko Sugiyama5Department of Pulmonary Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaArticle | Published in 2014 in European Respiratory JournalTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- Emergency department visits by adult asthma patients have been decreasing over the past two decadesBy Michiko Hibi, Akira Shiraki, Morihide Ando, Takashi Abe, Harunori Nakashima and Joe ShindoMichiko Hibi1Respiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanAkira Shiraki1Respiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanMorihide Ando1Respiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanTakashi Abe1Respiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanHarunori Nakashima1Respiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, JapanJoe Shindo1Respiratory Medicine, Ogaki municipal Hospital, Ogaki, Gifu, Japan
- Expression of CysLT2 receptors in asthmatic lung, and the roles in bronchoconstrictionBy Takeshi Nabe, Tomohiko Sekioka, Michiaki Kadode, Masanori Fujii, Takashi Abe, Michiaki Horiba, Shigekatsu Kohno and Kazuhito KawabataTakeshi Nabe1Faculty of Pharmaceutical Sciences, Setsunan University, Osaka, Japan2Pharmacology, Kyoto Pharmaceutical University, Kyoto, JapanTomohiko Sekioka2Pharmacology, Kyoto Pharmaceutical University, Kyoto, Japan3Biology & Pharmacology, Ono Pharmaceutical Co., Ltd, Osaka, JapanMichiaki Kadode2Pharmacology, Kyoto Pharmaceutical University, Kyoto, Japan3Biology & Pharmacology, Ono Pharmaceutical Co., Ltd, Osaka, JapanMasanori Fujii2Pharmacology, Kyoto Pharmaceutical University, Kyoto, JapanTakashi Abe4Pneumology, Ogaki Municipal Hospital, Gifu, JapanMichiaki Horiba4Pneumology, Ogaki Municipal Hospital, Gifu, JapanShigekatsu Kohno2Pharmacology, Kyoto Pharmaceutical University, Kyoto, JapanKazuhito Kawabata3Biology & Pharmacology, Ono Pharmaceutical Co., Ltd, Osaka, Japan
- The prognostic factor in patients with myositis-associated interstitial lung diseaseBy Akira Shiraki, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi and Joe ShindoAkira Shiraki1Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanMorihide Ando1Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanTakashi Abe1Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanHarunori Nakashima1Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanMichiko Hibi1Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, JapanJoe Shindo1Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, Japan
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosisBy Takashi Ogura, Hiroyuki Taniguchi, Arata Azuma, Yoshikazu Inoue, Yasuhiro Kondoh, Yoshinori Hasegawa, Masashi Bando, Shinji Abe, Yoshiro Mochizuki, Kingo Chida, Matthias Klüglich, Tsuyoshi Fujimoto, Kotaro Okazaki, Yusuke Tadayasu, Wataru Sakamoto and Yukihiko SugiyamaTakashi Ogura1Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, JapanHiroyuki Taniguchi2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanArata Azuma3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshikazu Inoue4Dept of Diffuse Lung Diseases and Respiratory Failure, Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, JapanYasuhiro Kondoh2Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Aichi, JapanYoshinori Hasegawa5Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, JapanMasashi Bando6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, JapanShinji Abe3Graduate School of Medicine Nippon Medical School, Tokyo, JapanYoshiro Mochizuki7Respiratory Medicine, Himeji Medical Center, Himeji, JapanKingo Chida8Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, JapanMatthias Klüglich9Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, GermanyTsuyoshi Fujimoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanKotaro Okazaki10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYusuke Tadayasu10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanWataru Sakamoto10Nippon Boehringer Ingelheim Co. Ltd, Tokyo, JapanYukihiko Sugiyama6Division of Pulmonary Medicine, Dept of Medicine, Jichi Medical University, Tochigi, Japan
- The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatmentsBy Hirohisa Kano, Akira Shiraki, Joe Shindoh, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi and Sho HoriHirohisa KanoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanAkira ShirakiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanJoe ShindohRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMorihide AndoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanTakashi AbeRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanHarunori NakashimaRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMichiko HibiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanSho HoriRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu Japan
- Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPDBy Keiko Wakahara, Yoshihiro Suzuki, Akira Shiraki, Toyokazu Sashio, Takashi Abe, Yukari Arakawa, Daiki Goto, Joe Shindoh and Yoshinori HasegawaKeiko Wakahara1Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi JapanYoshihiro Suzuki1Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi JapanAkira Shiraki2Department of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanToyokazu Sashio3Department of Internal Medicine, Meijo Hospital, Nagoya, Aichi JapanTakashi Abe2Department of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanYukari Arakawa3Department of Internal Medicine, Meijo Hospital, Nagoya, Aichi JapanDaiki Goto3Department of Internal Medicine, Meijo Hospital, Nagoya, Aichi JapanJoe Shindoh2Department of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanYoshinori Hasegawa1Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi Japan
- The analysis of prognostic factors in patients with interstitial lung diseasesBy Akira Shiraki, Morihide Ando, Takashi Abe, Harunori Nakashima, Michiko Hibi, Hirohisa Kano and Show HoriAkira ShirakiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMorihide AndoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanTakashi AbeRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanHarunori NakashimaRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanMichiko HibiRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanHirohisa KanoRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu JapanShow HoriRespiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu Japan
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series
